Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Too Sick For CAR-T? Kite Reports Cerebral Edema Death

T-cells attacking cancer_1200x675

Related Content

Juno Stresses Differences Between Its CAR-Ts As JCAR015 Trial Put On Hold Again

Nov 24 2016

Juno Ends JCAR015 Development In ALL, Cementing Third Place CAR-T Position

Mar 02 2017

BLA Accepted: Novartis Inches Ahead In CAR-T Race With Kite

Mar 30 2017

Related Companies

Kite Pharma, Inc.

Bristol Myers Squibb Company

National Cancer Institute

UCB S.A.

Roche Holding AG

Novartis AG

Additional Topics

ImmunoOncology Drug Safety Clinical Trials Research & Development Cancer BioPharmaceutical

More from Immuno-oncology

More from Anticancer

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window